Close Menu
TrenderHQTrenderHQ

    Subscribe to Updates

    Get the latest creative news and more from TrenderHQ.

    What's Hot

    Genetic testing for breast cancer: who should get it and what it means

    October 9, 2026

    Palliative care for breast cancer: improving quality of life at every stage

    October 9, 2026

    The cost of breast cancer care: financial hardship for patients and families

    October 9, 2026
    Facebook X (Twitter) Instagram
    TrenderHQTrenderHQ
    • Home
    • Buzz
    • Lifestyle
    • Stories
    • World News
    • Sports
    • Health
    • Videos
    • HQ
    TrenderHQTrenderHQ
    Home » Male breast cancer: A rare disease with a worse outcome
    Health

    Male breast cancer: A rare disease with a worse outcome

    Health DeskBy Health DeskOctober 9, 20265 Views
    WhatsApp Facebook Twitter Copy Link LinkedIn Telegram Email
    Male breast cancer

    The short answer: male breast cancer is rare, accounting for less than 1% of all breast cancer cases, but it has significantly worse outcomes than female breast cancer [2]. Men are typically diagnosed at an older age, at more advanced stages, and with larger tumors. Five-year overall survival is approximately 73% to 78% for men, compared with 83% to 86% for women [2][20]. The mortality rate is nearly three times higher for men even after adjusting for other factors [2]. There is no routine screening program for men, and public awareness is extremely low, which contributes to delayed diagnosis [13][15].

    Breast cancer is widely perceived as a women’s disease. This perception is understandable, given that it is about 100 times more common in women. But men have breast tissue too, and they can develop breast cancer. When they do, the consequences are often more severe.

    This article explains what the latest research shows about the epidemiology, risk factors, survival outcomes, and unique challenges of male breast cancer.

    How common is male breast cancer?

    Male breast cancer (MBC) contributes approximately 1% of total breast cancer diagnoses worldwide [1]. In the United States, a man’s lifetime risk of developing breast cancer is about 1 in 833, compared with 1 in 8 for women [11].

    Despite its rarity, the global burden is increasing. A 2025 analysis of the Global Burden of Disease Study found that incidence, mortality, and disability-adjusted life years for male breast cancer increased worldwide between 1990 and 2021 [1]. Eastern Sub-Saharan Africa had the highest incidence and mortality rates. Countries in the middle socio-demographic index quintile showed the fastest growth in age-standardized incidence [1].

    A separate analysis of Commonwealth countries found that middle-income regions had the highest incidence and mortality rates, while high-income regions had the lowest [8]. This pattern suggests that access to early detection and treatment plays a significant role in outcomes.

    Risk factors

    Several factors increase a man’s risk of developing breast cancer.

    Genetics

    The strongest genetic risk factor is BRCA2. Men who inherit a BRCA2 mutation have a 6% risk of developing breast cancer by age 70 [19]. BRCA1 mutations also increase risk, but BRCA2 is more commonly associated with male breast cancer [5].

    Other genes linked to increased risk include PALB2, CHEK2, and ATM [5]. Men with a significant family history of breast or ovarian cancer should be offered genetic counseling and testing [19].

    Age and hormonal factors

    Risk increases with age. Most male breast cancers are diagnosed in men over 60 [15]. Conditions that increase estrogen levels or decrease androgen levels, such as liver disease, obesity, and Klinefelter syndrome, can raise risk.

    Lifestyle and environmental factors

    The Global Burden of Disease analysis identified alcohol use, dietary risks, and tobacco use as risk factors for male breast cancer mortality, with dietary risks ranking first across all regions [1].

    Survival outcomes: worse than female breast cancer

    The evidence on male breast cancer survival is consistent and concerning. Multiple large studies have found that men fare worse than women at every stage.

    A 2025 propensity score-matched analysis of the US National Cancer Database included 24,055 men and over 2.5 million women with breast cancer [2]. Key findings:

    OutcomeMaleFemale
    Mean age at diagnosis65.6 years61.4 years [2]
    Stage IV at diagnosis7%4.7% [2]
    Node-positive disease18.5%15.5% [2]
    5-year overall survival73%83% [2]
    10-year overall survival54%70% [2]

    After propensity weighting, men had 2.8 times higher mortality than women [2]. Critically, survival rates for female breast cancer improved steadily from 2004 to 2015, but male breast cancer survival did not improve over the same period [2].

    A 2025 systematic review and meta-analysis reported similar figures: 5-year survival of 77.6% for men compared with 86.4% for women, and 3-year survival of 86.4% for men compared with 91.7% for women [20].

    A Korean nationwide registry study found that while breast cancer-specific survival was similar between sexes, overall survival was significantly lower in men (68.0% vs 79.0% at 10 years). The authors attributed this to higher non-cancer-related mortality in men [9].

    Why outcomes are worse

    Several factors explain the survival gap.

    Delayed diagnosis

    Men are more likely to be diagnosed at advanced stages [2]. There is no routine screening program for male breast cancer. Men are not taught to perform breast self-exams, and many do not know they can develop the disease [15].

    A case report described a man who waited one year from discovering a mass to seeking treatment. The authors identified social stigma and lack of public awareness as the core reasons for the delay [13].

    Biological differences

    Male breast cancers are more likely to be hormone receptor-positive: 88.5% are estrogen receptor-positive and 79.6% are progesterone receptor-positive, compared with 78.5% and 68% in women [2]. They are less likely to be HER2-positive or triple-negative [2].

    This receptor profile would normally suggest a better prognosis, yet outcomes are still worse. This paradox suggests that other factors, including later stage at diagnosis and differences in treatment, play a larger role than receptor status alone [2].

    Treatment differences

    Men are more likely to undergo mastectomy than breast-conserving surgery. In one Korean cohort, 92.6% of men had total mastectomy, compared with 50.4% of women who had breast-conserving surgery [16]. Men are also less likely to receive guideline-concordant care, partly because clinical trials have historically excluded them [17].

    Non-cancer mortality

    The Korean study found that overall survival was worse in men but breast cancer-specific survival was similar between sexes. This suggests that men with breast cancer are more likely to die from other causes, such as cardiovascular disease, which may reflect higher rates of comorbid conditions [9].

    The psychosocial burden

    Male breast cancer carries a unique psychosocial burden that is often overlooked.

    A 2026 systematic review of qualitative studies described male breast cancer patients as “marginalized individuals” caught between two cultural frameworks: they are men, but they have a disease that is culturally coded as female [6]. This creates a sense of isolation and stigma.

    Men often feel embarrassed and anxious about the diagnosis. Public awareness is extremely limited, and many healthcare providers have never encountered a male breast cancer patient [13]. This cognitive gap and stigma create a vicious cycle: insufficient awareness leads to neglect of symptoms, stigma exacerbates delayed care, and ultimately results in disease progression [13].

    A 2025 systematic review on quality of life found that men with breast cancer developed greater deficits in both physical and mental health compared with women facing the same disease [20]. Sexual dysfunction is a significant issue: a 2024 review found that 22% of men taking tamoxifen experienced sexual dysfunction or loss of libido, and 23% discontinued treatment specifically because of this side effect [20].

    Signs and symptoms

    The most common sign of male breast cancer is a painless lump beneath or behind the nipple [18]. Other warning signs include [11][18]:

    • Nipple inversion or changes in nipple direction
    • Nipple discharge, which may be clear or bloody
    • Skin dimpling, redness, or scaly patches
    • Swelling or thickening of breast tissue
    • Lumps in the armpit
    • An open wound or ulcer on the breast skin

    Many breast changes in men are benign, such as gynecomastia (enlarged breast tissue). But any new or persistent breast change should be evaluated by a healthcare provider [4].

    What is myth, not documented

    Myth: Men cannot get breast cancer. Men can and do get breast cancer. While rare, it represents about 1% of all breast cancer cases [1].

    Myth: Male breast cancer has the same outcomes as female breast cancer. The evidence shows that men have worse overall survival, are diagnosed at later stages, and have not seen the same improvements in survival over time [2][9][20].

    Myth: Male breast cancer is caused by the same factors as female breast cancer. While there is overlap, the genetic architecture differs. BRCA2 is more strongly associated with male breast cancer, while BRCA1 is more associated with female breast cancer [5].

    Myth: Men do not need to worry about breast changes. Any new lump, nipple change, or skin change in the breast should be evaluated promptly [18].

    The bottom line

    Male breast cancer is a rare but serious disease with worse outcomes than female breast cancer. Men are diagnosed later, at more advanced stages, and have not benefited from the same improvements in survival seen in women [2]. The reasons include lack of awareness, absence of screening programs, biological differences, and psychosocial barriers that delay diagnosis [13][15]. Addressing these disparities requires public education, clinical awareness, and research that includes men [17][20].

    Disclaimer

    This article is for informational purposes only and is not a substitute for professional medical advice. If you notice any breast changes or have concerns about your risk, consult a qualified healthcare provider. We welcome your feedback and corrections. Please contact us if you notice any errors.

    References

    • [1] The global, regional, and national disease burden and risk factors of male breast cancer from 1990 to 2021: an analysis of the Global Burden of Disease Study, PubMed. https://pubmed.ncbi.nlm.nih.gov/39945451/
    • [2] Clinical Characteristics and Survival Trends of Male Breast Cancer in the United States: A Propensity Score Matched Analysis, PubMed. https://pubmed.ncbi.nlm.nih.gov/40710438/
    • [3] Male breast cancer: a multicenter study to provide a guide for proper management, PubMed. https://pubmed.ncbi.nlm.nih.gov/38896332/
    • [4] Yes, Men Can Get Breast Cancer, Too, Cleveland Clinic Health Essentials. https://health.clevelandclinic.org/can-men-get-breast-cancer
    • [5] Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond, PubMed. https://pubmed.ncbi.nlm.nih.gov/38339330/
    • [6] “The marginalized”: A qualitative review of the illness experiences and psychological experiences of male breast cancer patients, ScienceDirect. https://www.sciencedirect.com/science/article/abs/pii/S146238892600222X
    • [7] Real-word study of racial/ethnic disparities and socioeconomic determinants of overall survival in male breast cancer, Europe PMC. https://europepmc.org/article/PPR/PPR981522
    • [8] An Analysis of Male Breast Cancer Incidence, Mortality, and Disease Burden Among Commonwealth Countries, PubMed. https://pubmed.ncbi.nlm.nih.gov/40636602/
    • [9] Long-term survival outcomes of male breast cancer: the propensity score matching analysis of nationwide registry database, PubMed. https://pubmed.ncbi.nlm.nih.gov/40782690/
    • [10] Breast cancer in men: a rare condition that needs to be better understood, PubMed. https://pubmed.ncbi.nlm.nih.gov/41203370/
    • [11] Breast Cancer in Men, National Cancer Institute. https://www.cancer.gov/types/breast/male-breast-cancer
    • [12] Cancer variation associated with the position of the mutation in the BRCA2 gene, PubMed. https://pubmed.ncbi.nlm.nih.gov/15131399/
    • [13] Male invasive breast carcinoma containing both mucinous and [case report], Gland Surgery. https://journals.lww.com/gs/fulltext/2026/01000/male_invasive_breast_carcinoma_containing_both.27.aspx
    • [14] Abstract P3-03-08: Clinical Characteristics of Male Breast Cancer by Race and Factors Predicting Survival, American Association for Cancer Research. https://aacrjournals.org/clincancerres/article/31/12_Supplement/P3-03-08/753758
    • [15] Long-term trends in the incidence of male breast cancer and nomogram for predicting survival in male breast cancer patients, PubMed. https://pubmed.ncbi.nlm.nih.gov/39814936/
    • [16] Survival pattern in male breast cancer: distinct from female breast cancer, PubMed. https://pubmed.ncbi.nlm.nih.gov/39007102/
    • [17] male breast cancer treatment, PubMed search results. https://pubmed.ncbi.nlm.nih.gov/?term=male+breast+cancer+treatment
    • [18] Dartmouth Cancer Center oncologist urges awareness of male breast cancer symptoms, Dartmouth Cancer Center. https://cancer.dartmouth.edu/stories/article/dartmouth-cancer-center-oncologist-urges-awareness-male-breast-cancer-symptoms
    • [19] Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada, PubMed. https://pubmed.ncbi.nlm.nih.gov/11899391/
    • [20] Breast Cancer in Men and Quality of Life: A Systematic Review, National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC12524050/

    Share this:

    • Share on Facebook (Opens in new window) Facebook
    • Share on X (Opens in new window) X
    Breast cancer Cancer
    Share. WhatsApp Facebook Twitter LinkedIn Email Telegram Copy Link
    Health Desk

    Health Desk publishes educational health information based on medical and public-health sources. Our articles are intended for general information and do not replace professional medical advice, diagnosis or treatment. Readers are encouraged to consult qualified healthcare professionals regarding personal health concerns. Corrections and feedback are welcome through our contact page. To advertise with us or support our cause through a donation, reach out via our contact page or email: hello@trenderhq.com

    Related Posts

    Genetic testing for breast cancer: who should get it and what it means

    October 9, 2026

    Palliative care for breast cancer: improving quality of life at every stage

    October 9, 2026

    The cost of breast cancer care: financial hardship for patients and families

    October 9, 2026
    Leave A Reply Cancel Reply

    Ads
    Demo
    Top Posts

    Odo Broni: Daddy Lumba’s Wife Priscilla Ofori

    July 30, 20252,817

    10 Simple Steps to Achieve Greatness in Your Life

    August 13, 20232,363

    British Man who posted luxury on social media gets drugged and murdered for his watches!

    January 13, 20232,125

    Easter dates for the next 20 years (2026 – 2045)

    March 14, 20261,088
    Don't Miss
    Health

    Genetic testing for breast cancer: who should get it and what it means

    October 9, 20267

    The short answer: genetic testing for breast cancer is recommended for people with a strong…

    Share this:

    • Share on Facebook (Opens in new window) Facebook
    • Share on X (Opens in new window) X

    Palliative care for breast cancer: improving quality of life at every stage

    October 9, 2026

    The cost of breast cancer care: financial hardship for patients and families

    October 9, 2026

    Breast cancer recurrence: what survivors need to know

    October 9, 2026

    Hormone replacement therapy and breast cancer risk: The updated evidence

    October 9, 2026

    HER2-positive breast cancer: How targeted therapy changed outcomes

    October 9, 2026

    Triple-negative breast cancer: Why it is harder to treat

    October 9, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo

    Subscribe to Updates

    Get the latest creative news and more from TrenderHQ.

    TrenderHQ © 2026 | powered by Intek Multimedia.

    • About Us
    • Contact
    • Privacy
    • Disclaimer
    • Services
    • Advertise

    Type above and press Enter to search. Press Esc to cancel.